These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15118370)

  • 1. c-kit Mutation in generalized lentigines associated with gastrointestinal stromal tumor.
    Shibusawa Y; Tamura A; Mochiki E; Kamisaka K; Kimura H; Ishikawa O
    Dermatology; 2004; 208(3):217-20. PubMed ID: 15118370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of loss-of-function and gain-of-function mutations of c-kit on the gastrointestinal tract.
    Hirota S; Isozaki K; Nishida T; Kitamura Y
    J Gastroenterol; 2000; 35 Suppl 12():75-9. PubMed ID: 10779223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
    Wardelmann E; Neidt I; Bierhoff E; Speidel N; Manegold C; Fischer HP; Pfeifer U; Pietsch T
    Mod Pathol; 2002 Feb; 15(2):125-36. PubMed ID: 11850541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors.
    Chen LL; Trent JC; Wu EF; Fuller GN; Ramdas L; Zhang W; Raymond AK; Prieto VG; Oyedeji CO; Hunt KK; Pollock RE; Feig BW; Hayes KJ; Choi H; Macapinlac HA; Hittelman W; Velasco MA; Patel S; Burgess MA; Benjamin RS; Frazier ML
    Cancer Res; 2004 Sep; 64(17):5913-9. PubMed ID: 15342366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours.
    Hirota S; Nishida T; Isozaki K; Taniguchi M; Nakamura J; Okazaki T; Kitamura Y
    J Pathol; 2001 Apr; 193(4):505-10. PubMed ID: 11276010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors.
    Taniguchi M; Nishida T; Hirota S; Isozaki K; Ito T; Nomura T; Matsuda H; Kitamura Y
    Cancer Res; 1999 Sep; 59(17):4297-300. PubMed ID: 10485475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recurrent duodenal gastrointestinal stromal tumor with a frameshift mutation resulting in a stop codon in KIT exon 13.
    Vu HA; Xinh PT; Kikushima M; Zhu Y; Tokuhara M; Tani M; Shimizu T; Saito K; Tokunaga K; Sato Y
    Genes Chromosomes Cancer; 2005 Feb; 42(2):179-83. PubMed ID: 15543597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients.
    Kinoshita K; Hirota S; Isozaki K; Ohashi A; Nishida T; Kitamura Y; Shinomura Y; Matsuzawa Y
    J Pathol; 2004 Jan; 202(1):80-5. PubMed ID: 14694524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.
    Lux ML; Rubin BP; Biase TL; Chen CJ; Maclure T; Demetri G; Xiao S; Singer S; Fletcher CD; Fletcher JA
    Am J Pathol; 2000 Mar; 156(3):791-5. PubMed ID: 10702394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of c-kit-activating mutations in gastrointestinal stromal tumors by high-resolution amplicon melting analysis.
    Willmore C; Holden JA; Zhou L; Tripp S; Wittwer CT; Layfield LJ
    Am J Clin Pathol; 2004 Aug; 122(2):206-16. PubMed ID: 15323137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).
    Ali S; Ali S
    Gene; 2007 Oct; 401(1-2):38-45. PubMed ID: 17659849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
    Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
    Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of gastric stromal tumors.
    Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
    J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
    Rubin BP; Singer S; Tsao C; Duensing A; Lux ML; Ruiz R; Hibbard MK; Chen CJ; Xiao S; Tuveson DA; Demetri GD; Fletcher CD; Fletcher JA
    Cancer Res; 2001 Nov; 61(22):8118-21. PubMed ID: 11719439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
    Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
    Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
    Bernet L; Zuñiga A; Cano R
    Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of c-kit gene mutation on prognosis of gastrointestinal stromal tumor].
    Ma DL; Liu XH; Bai CG; Xie Q; Feng F
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):140-4. PubMed ID: 15062057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation.
    Choi YR; Kim H; Kang HJ; Kim NG; Kim JJ; Park KS; Paik YK; Kim HO; Kim H
    Cancer Res; 2003 May; 63(9):2188-93. PubMed ID: 12727838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822Y.
    Thalheimer A; Schlemmer M; Bueter M; Merkelbach-Bruse S; Schildhaus HU; Buettner R; Hartung E; Thiede A; Meyer D; Fein M; Maroske J; Wardelmann E
    Am J Surg Pathol; 2008 Oct; 32(10):1560-5. PubMed ID: 18724244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles.
    Subramanian S; West RB; Corless CL; Ou W; Rubin BP; Chu KM; Leung SY; Yuen ST; Zhu S; Hernandez-Boussard T; Montgomery K; Nielsen TO; Patel RM; Goldblum JR; Heinrich MC; Fletcher JA; van de Rijn M
    Oncogene; 2004 Oct; 23(47):7780-90. PubMed ID: 15326474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.